America Great Health
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $391.7K | $294.7K | $204.3K | $104.6K | $195.7K | $5.5K | $0 | $0 |
| Cost of Revenue | $52.6K | $124.9K | $35.7K | $1.6M | $144.3K | $3.4K | $0 | $0 |
| Gross Profit | $339.1K | $169.8K | $168.6K | $-1.5M | $51.4K | $2.1K | $0 | $0 |
| Gross Margin | 86.6% | 57.6% | 82.5% | -1,417.9% | 26.2% | 38.5% | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $722.1K | $952.5K | $661.2K | $3.3M | $294.9K | — | — | — |
| Operating Income | $-382.9K | $-782.7K | $-492.6K | $-4.7M | $-243.6K | $-46.2K | $-46.8K | $-58.1K |
| Operating Margin | -97.8% | -265.6% | -241.1% | -4,523.8% | -124.5% | -843.1% | — | — |
| Interest Expense | $901.6K | $660.4K | $319.7K | $190.9K | $20.0K | $5.0K | $4.5K | $0 |
| Pretax Income | $-721.2K | $-1.2M | $-777.3K | $-4.9M | $-269.1K | $-51.1K | $-64.2K | $-58.6K |
| Income Tax Expense | — | — | — | — | $0 | $800 | $800 | $800 |
| Net Income | $-719.1K | $-1.2M | $-761.4K | $-4.9M | $-269.1K | $-51.9K | $-65.0K | $-59.4K |
| Net Margin | -183.6% | -414.2% | -372.7% | -4,706.2% | -137.5% | -948.4% | — | — |
| EPS (Basic) | $0.00 | $0.00 | $0.00 | — | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | — | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 21.14B | 21.12B | 21.09B | 21.09B | 21.07B | 20.24B | 20.24B | 20.24B |
| Shares Outstanding (Diluted) | 21.14B | 21.12B | 21.09B | 21.09B | 21.07B | 20.24B | 20.24B | 20.24B |
| Dividends Per Share | — | — | — | — | — | — | — | — |